Skip to main content

Atrial Fibrillation

Hightower Clinical is committed to driving progress in treating atrial fibrillation and enhancing patient care globally.

                       

About Atrial Fibrillation (AF) Study

Atrial Fibrillation (AF) is a common heart condition characterized by an irregular heart rhythm in the upper chambers (atria). Afib is one of the common types of arrythmias and present symptoms like fatigue, palpitations, difficulty in breathing, and dizziness.

Hightower Clinical conducted a study to evaluate the safety and effectiveness of the Amulet Left Atrial Appendage (LAA) occlusion device as an alternative to NOAC therapy in patients with non-valvular AF at increased risk for stroke. The goal was to provide insight into whether the device can be a safer and more effective long-term option for stroke prevention compared to NOACs.

Current Status

Not Recruiting

Study Count

1

Study Information

Atrial Fibrillation

Study NameProtocol NumberSponsor
Atrial Fibrillation

ABT-CIP-10310

Abbott

Frequently Asked Questions

What are the risk factors for developing atrial fibrillation?

Risk factors for atrial fibrillation include high blood pressure, heart disease, diabetes, obesity, excessive alcohol consumption, and a family history of AF.

What are the potential complications of atrial fibrillation

Atrial fibrillation can lead to serious complications, including an increased risk of stroke, heart failure, and blood clots.

Why would I participate in a clinical trial for atrial fibrillation?

Participating in a clinical trial can give you access to new treatments and help advance medical research, potentially improving care for yourself and others with atrial fibrillation.

Am I eligible for a clinical trial for atrial fibrillation?

Eligibility depends on factors like your type of atrial fibrillation, medical history, and whether you’re already receiving treatment like NOAC therapy.

Close Menu